What Researchers Did
A panel from the American Academy of Neurology and the American Headache Society reviewed published studies from June 1999 to May 2009 to see whether NSAIDs or complementary treatments help prevent migraine in adults.
What They Found
This evidence-based guideline update found that Petasites (butterbur) is effective for migraine prevention (Level A), out of 15 nontraditional, NSAID and complementary therapy articles drawn from 49 Class I or Class II articles. The panel reviewed 284 abstracts to reach those 49 articles. Fenoprofen, ibuprofen, ketoprofen, naproxen, naproxen sodium, MIG-99 (feverfew), magnesium, riboflavin and subcutaneous histamine are probably effective (Level B). Cyproheptadine, Co-Q10, estrogen, mefenamic acid and flurbiprofen are possibly effective (Level C). Montelukast is probably ineffective (Level B). For aspirin, indomethacin, omega-3 and hyperbaric oxygen, the data are conflicting or inadequate to support or refute use for migraine prevention.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The guideline drew only on studies published between June 1999 and May 2009, and only 49 of 284 abstracts reviewed were Class I or Class II evidence. For several treatments, including hyperbaric oxygen, the data were too conflicting or inadequate to reach a conclusion.